Cargando…
An ex vivo human aqueous humor-concentration comparison of two commercial bromfenac formulations
PURPOSE: The purpose of this study was to quantify the concentration of bromfenac in the aqueous humor utilizing high-performance liquid chromatography mass spectrometry between two commercial nonsteroidal anti-inflammatory drugs, using aqueous humor concentrations to characterize pharmacokinetic pr...
Autores principales: | Walters, Thomas R, Smyth-Medina, Robert J, Cockrum, Paul C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967376/ https://www.ncbi.nlm.nih.gov/pubmed/29849449 http://dx.doi.org/10.2147/OPTH.S170540 |
Ejemplares similares
-
In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits
por: Sheppard, John D., et al.
Publicado: (2018) -
Optimization of hyaluronan-enriched cubosomes for bromfenac delivery enhancing corneal permeation: characterization, ex vivo, and in vivo evaluation
por: Shoman, Nabil A., et al.
Publicado: (2023) -
Topical bromfenac reduces multiple inflammatory cytokines in the aqueous humour of pseudophakic patients
por: Matsumura, Takehiro, et al.
Publicado: (2021) -
Bromfenac 0.09% bioavailability in aqueous humor, prophylactic effect on cystoid macular edema, and clinical signs of ocular inflammation after phacoemulsification in a Mexican population
por: Palacio, Claudia, et al.
Publicado: (2016) -
Combination of Aflibercept and Bromfenac Therapy in Age-Related Macular Degeneration: A Pilot Study Aflibercept and Bromfenac in AMD
por: Wyględowska-Promieńska, Dorota, et al.
Publicado: (2015)